gener
peopl
diabet
higher
risk
develop
complic
infect
viru
type
diabet
common
type
diabet
associ
low
grade
chronic
inflamm
induc
excess
viscer
adipos
tissu
inflammatori
statu
affect
homeostat
glucos
regul
peripher
insulin
sensit
chronic
hyperglycemia
inflamm
caus
abnorm
ineffect
immun
respons
complex
multifactori
pathway
includ
decreas
mobil
polymorphonuclear
leukocyt
chemotaxi
phagocyt
activ
lower
secret
cytokin
respons
lipopolysaccharid
inhibit
tumor
necrosi
alpha
tnfa
activ
tcell
glycat
immunoglobulin
recent
data
coronaviru
diseas
caus
novel
coronaviru
confirm
diabet
along
advanc
age
major
risk
factor
advers
outcom
diabet
account
approxim
intens
care
unit
icu
admiss
accord
earli
analysi
small
cohort
wuhan
china
recent
data
itali
show
twothird
die
sever
acut
respiratori
syndrom
coronaviru
diabet
higher
risk
mortal
complic
among
peopl
diabet
similar
two
recent
coronaviru
outbreak
sar
affect
peopl
mainli
asia
begin
middl
east
respiratori
syndrom
mer
affect
person
mainli
saudi
arabia
odd
ratio
die
develop
sever
complic
follow
mer
coronaviru
merscov
infect
diabet
cooccur
rang
diabet
unquestion
major
contributor
merscov
diseas
sever
mortal
remark
human
dipeptidyl
peptidas
identifi
function
receptor
spike
protein
merscov
merscov
bind
receptorbind
domain
interact
cell
nuclear
factor
nfjb
highli
involv
pathogenesi
inflammatori
disord
antibodi
direct
inhibit
human
coronaviruserasmu
medic
center
hcovemc
infect
primari
human
bronchial
epitheli
cell
cell
enzym
type
ii
transmembran
glycoprotein
express
ubiquit
mani
tissu
includ
immun
cell
although
function
fulli
understood
yet
play
major
role
glucos
insulin
metabol
degrad
incretin
glucagon
like
peptid
glucosedepend
insulinotrop
polypeptid
ultim
lead
reduc
insulin
secret
abnorm
viscer
adipos
tissu
metabol
regul
postprandi
glucos
via
degrad
express
higher
viscer
adipos
tissu
directli
correl
adipocyt
inflamm
insulin
resist
play
also
import
role
immun
regul
activ
cell
upregul
express
nfjb
pathway
summar
increas
inflamm
type
diabet
via
catalyt
noncatalyt
mechan
note
enzymat
activ
caus
cleavag
may
affect
function
sever
cytokin
chemokin
growth
factor
better
understand
mechan
interact
coronaviru
transgen
mous
model
develop
one
studi
mice
made
suscept
http
elsevi
bv
right
reserv
diabet
hm
mice
delay
initi
inflamm
lung
character
reduc
cell
recruit
suggest
higher
rate
mortal
complic
individu
type
diabet
infect
merscov
could
associ
mediat
dysregul
immun
respons
anoth
studi
upon
inocul
merscov
human
knockin
ki
mice
human
exon
mous
locu
support
viru
replic
lung
develop
ill
interestingli
mice
lack
gene
encod
dpiv
refractori
develop
obes
insulin
resist
tempt
translat
data
human
explor
find
may
interest
context
outbreak
individu
type
diabet
obes
commonli
prescrib
inhibitor
andor
receptor
analog
inhibitor
divid
mimet
sitagliptin
vildagliptin
saxagliptin
peptid
mimet
alogliptin
linagliptin
inhibitor
target
enzymat
activ
consequ
block
breakdown
increas
insulin
secret
decreas
blood
glucos
level
patient
type
diabet
recent
inhibitor
mainli
receptor
analog
shown
provid
benefici
effect
go
beyond
glucos
lower
effect
howev
effect
inhibit
immun
respons
patient
type
diabet
controversi
complet
understood
metaanalysi
show
upper
respiratori
tract
infect
increas
significantli
inhibitor
treatment
compar
placebo
activ
compar
treatment
risk
respiratori
infect
inhibitor
compar
initi
inhibitor
associ
increas
risk
respiratori
tract
infect
contrari
antiinflammatori
antiadipogen
effect
associ
use
inhibitor
receptor
analog
reduc
macrophag
infiltr
directli
via
depend
signal
reduc
insulin
resist
inflamm
regul
macrophag
polar
describ
inhibit
activ
brief
overview
want
stimul
discuss
potenti
role
individu
type
diabet
unclear
whether
inhibit
modul
appropri
strategi
howev
may
repres
potenti
target
prevent
reduc
risk
progress
acut
respiratori
complic
type
diabet
may
add
infect
author
receiv
fund
extern
sourc
author
declar
conflict
interest
